Preview

Bone and soft tissue sarcomas, tumors of the skin

Advanced search

Aggressive fibromatosis - surgical approach as a part of combined treatment

Abstract

Aim of the study. To evaluate results of surgery alone in the treatment of aggressive fibromatosis during past 4 years. Materials and methods. From January 2006 till January 2010 in the dept, of orthopedic surgery 32 patients with extra abdominal aggressive fibromatosis underwent 38 surgeries (6 patients received additional surgeries due to local relapses). 9 male (28%) and 23 (72%) female patients were included in the trial. Median age was 31 year (16-70 y.o.). 12 patients (37,5%) out of 32 were with primary tumor, 18 (56%) with relapse tumors and 2 (6,5%) patients with undefinitive surgery made elsewhere. 12 (37%) patients out 32 underwent preplanned bone resections and 11 reconstructive surgery was done. Results. In 12 (31%) pathology reported positive margins (Rl) and the wrest were R0. 11 patients had disease progression 3 to 18 month after the surgery, 4 patients were lost of follow up. 7 patients are undergoing conservative treatment for tumor recurrence. 21 (66%) patient is alive without progression with follow up from 3 to 49 month (median follow up 17 months). Following negative prognostic factors were observed: multifocal tumor growth, tumor volume more then 1000 cm3, tumor location near the joints, in soft tissues of forearm, arm, hand, lower leg and foot. Conclusion. Negative margins does not guarantee that tumor will not relapse even with addition of RT or/and chemotherapy and in opposite, sometimes in patients with positive margins recurrence is not observed.

About the Authors

S. L. Daryalova
P.A. Herzen Moscow Research Oncological Institute Rosmedtechnology
Russian Federation


G. A. Frank
P.A. Herzen Moscow Research Oncological Institute Rosmedtechnology
Russian Federation


V. U. Karpenko
P.A. Herzen Moscow Research Oncological Institute Rosmedtechnology
Russian Federation


A. L. Ilushin
P.A. Herzen Moscow Research Oncological Institute Rosmedtechnology
Russian Federation


A. V. Bukharov
P.A. Herzen Moscow Research Oncological Institute Rosmedtechnology
Russian Federation


V. A. Derzhavin
P.A. Herzen Moscow Research Oncological Institute Rosmedtechnology
Russian Federation


S. V. Epifanova
P.A. Herzen Moscow Research Oncological Institute Rosmedtechnology
Russian Federation


O. V. Novikova
P.A. Herzen Moscow Research Oncological Institute Rosmedtechnology
Russian Federation


V. V. Teplyakov
P.A. Herzen Moscow Research Oncological Institute Rosmedtechnology
Russian Federation


References

1. Enzinger F.M., Weiss S.W., editors: Soft tissue tumors. St. Louis: Mosby. 1990.

2. Fletcher D.M., Unni K., Mertens F. World Health Organization Classification of Tumors. Pathology and Genetics. Tumors of Soft Tissue and Bone. IARC Press, Lyon. 2002.

3. Классификация сарком мягких тканей. Л., 1983.

4. Reitamo J.J., Scheinin Т.М., Havry P. The desmoid syndrome. New aspects in the cause, pathogenesis and treatment of the desmoidtumor. Am. J. Surg. 1986, v. 151, p. 230-237.

5. Чиссов В.И., Дарьялова С.Л. и соавт. Десмоидные фибромы. Готовы ли мы отказаться от хирургического лечения. Вестн. травмат. и ортопед, им. H.H. Приорова. 1998, № 1,с. 112-117.

6. Ковалев Д.В., Колосов П.В. Агрессивный фиброматоз: современное состояние проблемы. Анн. хир. 2002, № 4, с. 13-16.

7. Janinis J., Patriki М., Vini L. et al. The pharmacological treatment of aggressive fibromatosis: a systematic review. Ann Oncol. 2003, v. 14, p. 181-190.

8. Новикова О.В. Половые гормоны в этиологии, патогенезе и лечении десмоидных фибром. Диссертация на соискание ученой степени д-ра медицинских наук. М., 2008.

9. Humar A., Chou S., Carpenter В. Fibromatosis in infancy and childhood: the spectrum. J. Pediatr. Surg. 1993, v. 28 (11), p. 1446-1450.

10. Lewis J.J., Boland P.J., Leung D.H. et al. The enigma of desmoidtumors. Ann. Surg. 1999, v. 229 (6), p. 866-873.

11. Okuno S. The enigma of desmoid tumors. Curr. Treat Options Oncol. 2006, v. 7 (6), p. 438-443.

12. Huang K., Fu H., Shi Y.Q. et al. Prognostic factors for extraabdominal and abdominal wall desmoids: A 20-year experience at a single institution. J. Surg. Oncol. 2009, v. 96, p. 52-56.

13. Lev D., Kotilingam D., Wei C. et al. Optimizing treatment of desmoidtumors. J. Clin. Oncol. 2007, p. 25 (13), p. 1785-1791.

14. Кононенко Н.Г., Ковальчук Э.Н., Галахин K.A. и соавт. Агрессивный фиброматоз полости малого таза. Хирургия. 1994, № 9, с. 39-42.

15. Rock M.G., Pritchard D.J., Reiman Н.М. et al. Extrtra-abdominal desmoids tumors. J. Bone Joint. Surg. Am. 1984, v. 66A, p. 1369-1374.

16. Leithner A., Gapp M. et al. Margins in extra-abdominal desmoid tumors: a comparative analysis. J. Surg. Oncol. 2004, v. 86, p. 152-156.

17. Faulkner L.B., Hajdu S.I., Kher U. et al. Pediatric desmoids tumor: retrospective analysis of 63 cases. J. Clin. Oncol. 1995, v. 13, p. 2813-2818.

18. Pignatti G., Barbanti-Brodano G., Ferrari D. et al. Extra-abdominal desmoids tumor. A study of 83 cases. Clin. Orthop. 2000, v. 375, p. 207-213.


Review

For citations:


Daryalova S.L., Frank G.A., Karpenko V.U., Ilushin A.L., Bukharov A.V., Derzhavin V.A., Epifanova S.V., Novikova O.V., Teplyakov V.V. Aggressive fibromatosis - surgical approach as a part of combined treatment. Bone and soft tissue sarcomas, tumors of the skin. 2010;(4):34-39. (In Russ.)

Views: 118


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2219-4614 (Print)
ISSN 2782-3687 (Online)